Biologics contract development organizations provide complete services from cell line development to long term commercial supply of biological products. They offer various services including development of cell lines, analytical and bio-analytical methods, upstream and downstream processes, and formulations and quality assessment. This is type of outsourcing where manufacturer enters into formal agreement with another manufacturing organization for its parts, components, and products.
Market Drivers
Rise in adoption of advanced technologies for biological production is the key driving factor which is expected to boost the global biologics contract development market growth. Furthermore, Increase in outsourcing of research and development activities by pharma and bio-pharma companies and favorable regulatory environment for clinical trials in developing nations will positively contribute the market growth. Moreover, increase in number of mergers and collaborations will propel the market growth. For instance, in March 2019, Thermo Fischer Scientific had announced that it will acquire Brammer Bio, which is leading viral vector contract developer for cell and gene therapies. The main aim of this acquisition is strengthen its product portfolio in the area of gene therapy. In addition to that, increase in prevalence of various diseases such as cancer, neurological disorders, and cardiovascular diseases will fuel the market growth. For instance, as per the World Health Organization (WHO) approximately 8.2 million people die each year due to cancer worldwide. Many biologics contract organizations are now shifting to Single Use Bioreactors that offer lower up front capital costs, improved throughputs, and greater manufacturing flexibility will drive the biologics contract development market growth.
Market Restraints
However, change in trade policies between countries is the major challenging factor which is expected to hinder the global biologics contract development market growth during this analysis period.
Market Segmentation
Global Biologics Contract Development Market is segmented into source such as Microbial, Mammalian, and Others, by product service such as Cell Line Development, Process Development (Upstream, and Downstream), product ( MABs, Recombinant Proteins, and Others), and Others. Further, market is segmented into disease indication such as Oncology, Immunological Disorder, Cardiovascular Disorder, Hematological Disorder, and Others.
Also, Global Biologics Contract Development Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as WuXi Biologics, Fujifilm Diosynth Biotechnologies, Abzena Ltd., AGC Biologics, KBI Biopharma, SE Thermo Fisher (Patheon), LakePharma, Genscript Biotech Corporation, Bionova Scientific, and Boehringer Ingelheim BioXcellence
Market Taxonomy
By Source
By Product Service
By Disease Indication
By Region
Key Questions Addressed by the Report
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5.1 Y-o-Y Growth Comparison, By Source
5.2 Global Biologics Contract Development Market Share Analysis, By Source
5.3 Global Biologics Contract Development Market Size and Forecast, By Source
5.3.1 Microbial
5.3.2. Mammalian
5.3.3 Others
6.1 Y-o-Y Growth Comparison, By Product Service
6.2 Global Biologics Contract Development Market Share Analysis, By Product Service
6.3 Global Biologics Contract Development Market Size and Forecast, By Product Service
6.3.1Cell Line Development
6.3.2 Process Development
6.2.2.1 Upstream
6.2.2.2 Downstream
6.3.3. Product
6.3.3.1 MABs
6.3.3.2. Recombinant Process
6.3.3.3. Others
6.3.3.3. Others
7.1 Y-o-Y Growth Comparison, By Diseases Indication
7.2 Global Biologics Contract Development Market Share Analysis, By Diseases Indication
7.3 Global Biologics Contract Development Market Size and Forecast, By Diseases Indication
7.3. 1 Oncology
7.3.2. Immunological Disorder
7.3.3. Cardiovascular Disorder
7.3.4. Hematological Disorder
7.3.5. Others
8.1 Global Biologics Contract Development Market Share Analysis, By Region
8.2 Global Biologics Contract Development Market Share Analysis, By Region
8.3 Global Biologics Contract Development Market Size and Forecast, By Region
9.1 Introduction
9.2 North America Biologics Contract Development Market Share Analysis, By Source
9.3 North America Biologics Contract Development Market Size and Forecast, By Product Service
9.4 North America Biologics Contract Development Market Size and Forecast, By Diseases Indication
9.5 North America Biologics Contract Development Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10.1 Introduction
10.2 Europe Biologics Contract Development Market Share Analysis, By Source
10.3 Europe Biologics Contract Development Market Size and Forecast, By Product Service
10.4 Europe Biologics Contract Development Market Size and Forecast, By Diseases Indication
10.5 Europe Biologics Contract Development Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11.1 Introduction
11.2 Asia Pacific Biologics Contract Development Market Share Analysis, By Source
11.3 Asia Pacific Biologics Contract Development Market Size and Forecast, By Product Service
11.4 Asia Pacific Biologics Contract Development Market Size and Forecast, By Diseases Indication
11.5 Asia Pacific Biologics Contract Development Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12.1 Introduction
12.2 Latin America Biologics Contract Development Market Share Analysis, By Source
12.3 Latin America Biologics Contract Development Market Size and Forecast, By Product Service
12.4 Latin America Biologics Contract Development Market Size and Forecast, By Diseases Indication
12.5 Latin America Biologics Contract Development Market Size and Forecast, Country
13.1 Introduction
13.2 Middle East Biologics Contract Development Market Share Analysis, By Source
13.3 Middle East Biologics Contract Development Market Size and Forecast, By Product Service
13.4 Middle East Biologics Contract Development Market Size and Forecast, By Diseases Indication
13.5 Middle East Biologics Contract Development Market Size and Forecast, By Country
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15.1 WuXi Biologics
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Boehringer Ingelheim BioXcellence
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
